HCW Biologics enters exclusive distribution deal for HCW11-006
HCW Biologics entered an exclusive distribution agreement with Akron Biotech to commercialize HCW11-006 as a reagent used to support production of highly functional human CAR-T cells.
Story updates
12:57:16 PM UTC
SquawkNews
Agreement includes pre-payment commitments for product sales and distribution of the second-generation multi-cytokine-based HCW11-006 for use as a reagentAkron is a leading supplier of critical ancillary materials and accessory molecules for clinical and commercial scale-up of cell, gene and regene…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.